| Literature DB >> 26731546 |
Maho Yagi-Utsumi1,2, Koichi Kato1,2, Katsuyuki Nishimura3.
Abstract
Various neurodegenerative disorders are ascribed to pathogenic molecular processes involving conformational transitions of amyloidogenic proteins into toxic aggregates characterized by their β structures. Accumulating evidence indicates that neuronal cell membranes provide platforms for such conformational transitions of pathogenic proteins as best exemplified by amyloid β (Aβ). Therefore, membrane-bound Aβ species can be promising targets for the development of novel drugs for Alzheimer's disease. In the present study, solid-state nuclear magnetic resonance spectroscopy has elucidated the membrane-induced conformation of Aβ, in which the disordered N-terminal segment is followed by the stable C-terminal β strand. The data provides an insight into the molecular processes of the conformational transition of Aβ coupled with its assembly into parallel β structures.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26731546 PMCID: PMC4701388 DOI: 10.1371/journal.pone.0146405
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Solid-state NMR correlation spectra of [U-13C, 15N] Aβ(1–40) bound to DMPC bilayers for signal assignments.
(A) 13C-CTUC-COSY homonuclear correlation spectrum. (B) NCO and (C) NCA heteronuclear correlation spectra based on DCP. All measurements were performed at 20°C for the sample (DMPC/Aβ(1–40) molar ratio = 10/1) in lyophilized and dry state.
Summary of 13C, 15N isotropic chemical shifts with assignments of peaks for [U-13C, 15N] Aβ(1–40) incorporated into DMPC bilayers obtained by solid-state NMR.
| Residue | Chemical shifts (ppm) | |||||
|---|---|---|---|---|---|---|
| CO | Cα | Cβ | Cγ | Cδ | N | |
| V24 | 173.6 | 58.1 | 32.4 | 19.7 | 125.7 | |
| G25 | 170.2 | 46.1 | 118.1 | |||
| S26 | 171.0 | 54.8 | 65.6 | 107.9 | ||
| N27 | 172.0 | 50.6 | 39.0 | 117.4 | ||
| K28 | 171.2 | 54.3 | 126.7 | |||
| G29 | 171.2 | 44.0 | 111.6 | |||
| A30 | 173.5 | 48.0 | 20.7 | 127.7 | ||
| I31 | 172.5 | 59.3 | 38.7 | 26.6, 17.5 | 12.0 | 125.5 |
| I32 | 174.5 | 56.0 | 40.6 | 25.1, 15.5 | 12.1 | 125.9 |
| G33 | 170.4 | 47.2 | 115.7 | |||
| L34 | 173.0 | 51.8 | 44.2 | 23.9 | 26.8 | 115.8 |
| M35 | 172.0 | 52.3 | 35.4 | 29.7 | 121.3 | |
| V36 | 172.6 | 57.2 | 34.4 | 21.3 | 124.6 | |
| G37 | 169.3 | 43.7 | 111.3 | |||
| G38 | 170.0 | 42.3 | 102.5 | |||
| V39 | 171.4 | 58.6 | 33.4 | 19.8 | 120.8 | |
| V40 | ||||||
13C and 15N isotropic chemical shifts were referenced to 1H TMS by using secondary reference of adamantane and glycine for 13C and 15N, respectively.
Fig 2Solid-state NMR 13C homonuclear through-space correlation spectra of [U−13C, 15N] Aβ(1–40) bound to DMPC MLVs acquired by DARR/RAD with mixing times of (A) 10 ms and (B) 100 ms, respectively.
All measurements were performed at 20°C for the sample (DMPC/Aβ(1–40) molar ratio = 10/1) in lyophilized and dry state.
Fig 3Structural model of Aβ(1–40) bound to DMPC bilayers characterized by solid-state NMR analyses together with amino acid sequence of Aβ(1–40).